Deep Learning Predicts Risk for Childhood Obesity Over Three Years
By Lori Solomon HealthDay Reporter
WEDNESDAY, Nov. 13, 2024 -- A deep learning model can predict the risk for obesity for young children using only routinely collected electronic health record (EHR) data, according to a study published in the December issue of Obesity Pillars.
Mehak Gupta, Ph.D., from Southern Methodist University in Dallas, and colleagues developed predictive models of childhood obesity using advanced machine learning methods applied to a large unaugmented EHR dataset (36,191 children aged 0 to 10 years).
The researchers found that results were mostly better or comparable to existing studies, with the model achieving an area under the receiver operating characteristic curve above 0.8 in all cases (with most cases around 0.9) for predicting obesity within the next three years for children 2 to 7 years of age. The model’s robustness was validated, with top predictors matching important risk factors of obesity.
"Our model can predict the risk of obesity for young children at multiple time points using only routinely collected EHR data, greatly facilitating its integration into clinical care," the authors write. "Our model can be used as an objective screening tool to provide clinicians with insights into a patient's risk for developing obesity so that early lifestyle counseling can be provided to prevent future obesity in young children."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted November 2024
Read this next
Generative AI Model for Draft Radiological Reporting Improves Documentation Efficiency
THURSDAY, June 12, 2025 -- Clinical use of artificial intelligence (AI)-generated draft radiograph reports is associated with improved radiologist documentation efficiency while...
Real-World Weight Loss With Semaglutide, Tirzepatide Less Than That Seen in Clinical Trials
THURSDAY, June 12, 2025 -- For patients with obesity initiating pharmacotherapy with semaglutide or tirzepatide, weight loss at one year is 8.7 percent on average, which is lower...
Mitochondrial Genetics Key to Metastatic Melanoma Immunotherapy Resistance
THURSDAY, June 12, 2025 -- For patients with metastatic melanoma, mitochondrial (MT) haplogroup T (HG-T) is associated with resistance to an anti-programmed cell death...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.